Smalley, Keiran S M <br/><br/>
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells.  [electronic resource] 

 -  Cancer research  Jan 2007 
 - 209-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-06-1538  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Melanoma--drug therapy<br/>Mitochondria--drug effects<br/>Organometallic Compounds--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Ruthenium--chemistry<br/>Tumor Suppressor Protein p53--biosynthesis<br/>Up-Regulation